Skip to content

MassBio

Massachusetts Biotechnology Council

Open search form
  • Sign In/Create Account
  • Pay Company Dues
  • Become a Member
  • Resources
    • 2023 Industry Snapshot
    • 2022 Massachusetts Biopharma Funding Report
    • 2022 MA Life Sciences Workforce Analysis Report
    • 2021 State of Diversity, Equity, & Inclusion Report
    • Economic Development
    • Biopharma Startup Toolkit
    • Career Center
    • MassBioEd
  • Events
    • Events Calendar
    • Overview of Events
    • Get Involved
  • Membership
    • Member Directory
    • Benefits of Membership
    • Savings and Rewards
    • Member News
    • Become a Member
    • Member Rates
    • Pay Company Dues
  • Savings & Rewards
    • MassBioEdge
  • Conference Center
    • MassBioHub
  • Programs
    • Bioversity at Southline Boston
    • State of Possible 2025 Report
    • Diversity, Equity, and Inclusion
    • Policy & Advocacy
    • Partnering Opportunities
    • MassBioDrive
    • Digital Health
    • BioReady Communities
  • About Us
    • About Us
    • News & Thought Leadership
    • Sponsorship Opportunities
    • Staff
    • Board of Directors
    • FAQs
    • Contact Us
  • Sign In/Create Account
  • Pay Company Dues
  • Become a Member
Open search form

Member Directory

Click to Open Main Menu

Nilogen Oncosystems

Life Sciences | Contract Research & Manufacturing
Tampa, FL 8134403588 Website www.twitter.com/nilogenonc LinkedIn Facebook

Overview

Nilogen Oncosystems is a CLIA-certified contract research organization offering immuno-oncology drug development services for pharmaceutical and biotechnology companies. Our proprietary 3D ex vivo drug testing platform utilizes fresh patient tumor tissue with intact tumor immune microenvironment to accurately assess therapeutic efficacy of immuno-oncology drugs and to develop rationale drug combination strategies. Through comprehensive correlative studies between ex-vivo drug responses and clinical, cellular and molecular aspects of tumors, Nilogen aims to develop companion diagnostics to facilitate biomarker-driven drug development efforts and personalized medicine while reducing the cost and risk of bringing a new drug to market.

Company News

News

Nilogen To Present At AACR 2023

Apr 07, 2023

Posted by Nilogen Oncosystems

See all Members

Massachusetts Biotechnology Council

700 Technology Square, 5th Floor
Cambridge, MA 02139
617.674.5100

  • Contact
  • Privacy Policy
  • Fulfillment Policy
  • © 2023 All Rights Reserved